Literature DB >> 24667726

Rare cancers: work in progress in Europe.

P G Casali1.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24667726     DOI： 10.1093/annonc/mdu033

Source DB:  PubMed          Journal:  Ann Oncol        ISSN： 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  3 in total

1.  Correlation between S-1 treatment outcome and expression of biomarkers for refractory thymic carcinoma.

Authors:  Yusuke Okuma; Yukio Hosomi; Shingo Miyamoto; Masahiko Shibuya; Tatsuru Okamura; Tsunekazu Hishima
Journal:  BMC Cancer       Date:  2016-02-25       Impact factor: 4.430

Review 2.  Rare cancers: Challenges & issues.

Authors:  Raveendran K Pillai; K Jayasree
Journal:  Indian J Med Res       Date:  2017-01       Impact factor: 2.375

3.  Phase II trial of S-1 treatment as palliative-intent chemotherapy for previously treated advanced thymic carcinoma.

Authors:  Yusuke Okuma; Yasushi Goto; Fumiyoshi Ohyanagi; Kuniko Sunami; Yoshiro Nakahara; Satoru Kitazono; Keita Kudo; Yuichi Tambo; Shintaro Kanda; Noriko Yanagitani; Atsushi Horiike; Hidehito Horinouchi; Yutaka Fujiwara; Hiroshi Nokihara; Noboru Yamamoto; Makoto Nishio; Yuichiro Ohe; Yukio Hosomi
Journal:  Cancer Med       Date:  2020-08-19       Impact factor: 4.452
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.